Top Story

Campaign focuses on reducing HBV in Chinese city

August 22, 2014

The implementation phase of a cooperative that focuses on public awareness of hepatitis B virus in a city in China has laid vital groundwork, according to recent study results.

The Hepatitis B Foundation joined forces with the Haimen City Center for Disease Control and Prevention (HCCDC) for a 3-year campaign to educate clinicians, civic leaders and the city’s general population of 1 million residents on hepatitis B virus (HBV). Researchers from the Doylestown, Pa.-foundation, including Chari Cohen, MPH, DrPH, said chronic HBV is particularly prominent in Haimen City.

In the Journals

Diabetes independently linked with infection, ascites risk in CHC, cirrhosis

August 21, 2014
Diabetes was an independent prognostic factor for various liver-related outcomes, including development of bacterial infection and ascites, among patients with chronic…
Industry News

Sofosbuvir/ledipasvir expected to gain market share

August 20, 2014
Forty percent of specialists surveyed intend to prescribe the investigational combination treatment sofosbuvir/ledipasvir in the next 6 months to patients with hepatitis…
figure Industry News

World Hepatitis Alliance launches HCV Quest

August 19, 2014
The World Hepatitis Alliance has created HCV Quest, a global survey that provides a forum for patients with hepatitis C virus, according to an announcement on the…

Top 5 Questions on New Treatments for Chronic Hepatitis C Infection

10/11/2013
Learn more about new medications on the horizon for treating HCV infection.
More »
Meeting News Coverage Video
figure

Tenofovir/entecavir recommended for HBV patients with malignancy

May 16, 2014
CHICAGO — Spilios Manolakopoulos, MD, of the internal medicine and hepatology departments at…
More »

Top 10 Questions on HCV Infection

10/11/2013
Gain expert insight on HCV infection, including symptoms, age-based screening guidelines and treatment…
More »

Filter By:

figure In the Journals

Campaign focuses on reducing HBV in Chinese city

August 22, 2014
The implementation phase of a cooperative that focuses on public awareness of hepatitis B virus in a city in China has laid vital groundwork…
In the Journals

Diabetes independently linked with infection, ascites risk in CHC, cirrhosis

August 21, 2014
Diabetes was an independent prognostic factor for various liver-related outcomes, including development of bacterial infection and ascites, among…
Industry News

Sofosbuvir/ledipasvir expected to gain market share

August 20, 2014
Forty percent of specialists surveyed intend to prescribe the investigational combination treatment sofosbuvir/ledipasvir in the next 6 months to…
figure Industry News

World Hepatitis Alliance launches HCV Quest

August 19, 2014
The World Hepatitis Alliance has created HCV Quest, a global survey that provides a forum for patients with hepatitis C virus, according to an…
In the Journals

Advanced sequencing detected infection in patients with HIV/HCV after therapy

August 19, 2014
Next-generation sequencing revealed persisting strains of infection in men who have sex with men coinfected with HIV and hepatitis C virus who…
In the Journals

HCV epidemic emerging in young, non-urban injection drug users

August 18, 2014
New data indicate a rising incidence of hepatitis C infection among young, primarily white, non-urban people who inject drugs, according to CDC…
Industry News

Incivek expected to be discontinued by October

August 15, 2014
Vertex Pharmaceuticals expects to discontinue sales of its protease inhibitor treatment for hepatitis C virus by October, according to a company…
In the Journals

High sCD163 levels predicted fibrosis in patients with HCV, HBV

August 15, 2014
Increased levels of soluble CD163 were independently associated with fibrosis among patients with chronic hepatitis C virus and chronic hepatitis B…
In the Journals

HCV costs, mortality could increase in Australia by 2030

August 13, 2014
Australia could experience an increase in hepatitis C virus-related mortality and rising costs if current treatment options and their outcomes remain…
figure In the Journals

Telaprevir resulted in higher SVR in Japanese patients with HCV

August 11, 2014
Japanese patients with chronic hepatitis C virus genotype 1 treated with telaprevir combined with pegylated interferon alfa-2b and ribavirin achieved…
More Headlines »